Table 3

Multivariate analysis of disease specific survival and overall survival
Variables Disease-specific survival Overall survival
N HR 95% CI p HR 95% CI p
Stage
NMIBC 82 1 1
MIBC 60 13.61 2.79–66.39 0.001 7.63 2.25–25.92 0.001
Combined immunostaining score for CXCL1
None / Low 34 1 1
Moderate 53 1.57 0.17–14.58 0.69 1.17 0.21–6.36 0.86
High 55 3.05 0.34–27.16 0.32 2.08 0.39–10.98 0.39

HR Hazard ratio, 95% CI 95% confidence interval, NMIBC Non-muscle invasive bladder cancer, MIBC Muscle invasive bladder cancer.

Miyake et al.

Miyake et al. BMC Cancer 2013 13:322   doi:10.1186/1471-2407-13-322

Open Data